Phibro Animal Health (PAHC) Accumulated Expenses (2013 - 2026)

Phibro Animal Health's Accumulated Expenses history runs 14 years deep, the most recent figure standing at $129.4 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 935.33% year-over-year to $129.4 million; the TTM figure through Mar 2026 stood at $129.4 million (up 935.33% YoY), while the FY2025 annual figure was $139.0 million, up 56.58% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $129.4 million, up from $44.1 million in the prior quarter.
• The five-year high for Accumulated Expenses was $139.0 million in Q2 2025, with the low at $3.4 million in Q3 2023.
• The 5-year median for Accumulated Expenses is $29.4 million (2023), against an average of $48.6 million.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses jumped 7160.44% in 2022, then slumped 94.99% in 2023.
• Phibro Animal Health's Accumulated Expenses stood at $71.7 million in 2022, then tumbled by 61.73% to $27.4 million in 2023, then plunged by 48.01% to $14.3 million in 2024, then soared by 209.32% to $44.1 million in 2025, then soared by 193.38% to $129.4 million in 2026.
• Business Quant data shows PAHC's Accumulated Expenses at $129.4 million in Q1 2026, $44.1 million in Q4 2025, and $20.8 million in Q3 2025.